Sensus Healthcare price to free cash flow SRTS

Market value divided by free cash flow over the last twelve months, since 2020.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 153×; May 2026
6-year median: 39.4×
6-year range: 6.3× to 276×
Peer median: 10.9×

Sensus Healthcare's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in May 2026, at 153×.

On the days it had one over the last 6 years, its median was 39.4×, from 6.3× in May 2020 to 276× in Feb 2021.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	153×	29.3×	223×
2025	28.7×	12.3×	64.6×
2024	56.5×	55.7×	69.7×
2023	12.6×	12.6×	22.6×
2022	18.3×	14.7×	202×
2021	128×	88.2×	276×
2020	233×	6.3×	236×

Against its peers

Companies in Medical - Instruments & Supplies nearest Sensus Healthcare's size, closest first, today.

Company	Price to free cash flow
SRTSSensus Healthcare	n/m
APTAlpha Pro Tech	9.7×
NEPHNephros	n/m
KEQUKewaunee Scientific	8.7×
PDEXPro DEX	29.5×
UTMDUtah Medical Products	20.6×
INFUInfuSystem	12.1×
EMBCEmbecta	2.3×
Peer median	10.9×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Sensus Healthcare

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.